Oaktree Acquisition III Life Sciences postpones shareholder meeting to Oct. 23, 2026
OACC•Oaktree Acquisition III Life Sciences postponed its shareholder meeting from Oct. 16 to Oct. 23, 2026, to solicit additional proxy votes. Shareholders will consider extending the deadline to complete an initial business combination.
1. Meeting postponed
The shareholder meeting will begin at 10 a.m. Eastern Time in New York, with virtual participation available. Previously submitted proxies remain valid unless properly revoked, and shareholders who have already voted need take no further action unless they want to change their vote.
